Alkem Laboratories Limited announces the completion of its acquisition of Bombay Ortho Industries, expanding its footprint in the medical technology sector.
On April 17, 2025, Alkem Laboratories Limited revealed that its wholly-owned subsidiary, Alkem Medtech Private Limited, has successfully acquired 100% of the stake in Bombay Ortho Industries Private Limited.
This acquisition was completed in accordance with the terms outlined in the share purchase and share subscription agreement dated March 15, 2025. As a result, Bombay Ortho Industries has now become a wholly owned step-down subsidiary of Alkem Laboratories.
Impact of the acquisition on Alkem Laboratories' growth
This acquisition serves as a strategic move by Alkem Laboratories to diversify further and enhance its market presence in the rapidly growing MedTech industry. The acquisition of Bombay Ortho is expected to open up new avenues for growth, with both companies being well-positioned to benefit from this collaboration.
By adding Bombay Ortho's capabilities to its existing portfolio, Alkem Laboratories strengthens its capacity to cater to the ever-increasing demand for advanced medical technologies and devices.
Alkem Laboratories' expanded MedTech focus
Alkem Laboratories has long been known for its strong foundation in the pharmaceutical industry. The company has made substantial strides in both domestic as well as international markets, offering a range of pharmaceutical formulations and nutraceuticals.
The acquisition of Bombay Ortho Industries allows Alkem Laboratories to extend its expertise into the medical device space, complementing its existing operations. As a result, Alkem Laboratories is now better equipped to provide comprehensive healthcare solutions, further solidifying its position as a world leader in healthcare innovation.
Future prospects and market growth
As of 11:00 AM on April 17, 2025, the shares of Alkem Laboratories are down by 0.72%, at ₹4920.70 per share on the Bombay Stock Exchange (BSE). The completion of the acquisition is expected to contribute to the company's future growth, with the potential for new product development and enhanced operational efficiencies in the MedTech field.
This move also aligns with their strategy to tap into the growing global demand for medical technology products and services. Investors and stakeholders can look forward to increased opportunities as the company integrates Bombay Ortho's capabilities into its portfolio.
For android only